Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Sell
40
NOC Quote, Financials, Valuation and Earnings
Last price:
$487.92
Seasonality move
:
3.05%
Day range:
$489.48 - $496.21
52-week range:
$418.60 - $555.57
Dividend yield:
1.67%
P/E ratio:
19.48x
P/S ratio:
1.79x
P/B ratio:
4.74x
Volume:
830.1K
Avg. volume:
1.3M
1-year change:
5.17%
Market cap:
$71B
Revenue:
$41B
EPS (TTM):
$25.33
Analysts' Opinion
-
Consensus RatingNorthrop Grumman has received a consensus rating of Hold. The company's average rating is a Hold based on 10 Buy ratings, 11 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $542.32, Northrop Grumman has an estimated upside of 9.93% from its current price of $493.33.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $463.83 representing 100% downside risk from its current price of $493.33.
Fair Value
-
According to the consensus of 21 analysts, Northrop Grumman has 9.93% upside to fair value with a price target of $542.32 per share.
NOC vs. S&P 500
-
Over the past 5 trading days, Northrop Grumman has overperformed the S&P 500 by 0.6% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Northrop Grumman does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Northrop Grumman revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Northrop Grumman reported revenues of $9.5B.
Earnings Growth
-
Northrop Grumman earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Northrop Grumman reported earnings per share of $3.32.
Enterprise value:
83.5B
EV / Invested capital:
2.86x
Price / LTM sales:
1.79x
EV / EBIT:
16.39x
EV / Revenue:
2.07x
PEG ratio (5yr expected):
0.25x
EV / Free cash flow:
47.01x
Price / Operating cash flow:
40.62x
Enterprise value / EBITDA:
12.84x
Gross Profit (TTM):
$7.8B
Return On Assets:
7.68%
Net Income Margin (TTM):
9.19%
Return On Equity:
25.23%
Return On Invested Capital:
12.53%
Operating Margin:
6.05%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $37.1B | $40.1B | $40.4B | $10.1B | $9.5B | |
| Gross Profit | $7.6B | $6.7B | $7.8B | $2.1B | $1.6B | |
| Operating Income | $3.7B | $2.8B | $4B | $1.1B | $573M | |
| EBITDA | $7.5B | $4.4B | $6.5B | $1.6B | $1.1B | |
| Diluted EPS | $30.86 | $14.34 | $25.33 | $6.32 | $3.32 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $12.3B | $11.6B | $12.8B | $14.8B | $13.3B | |
| Total Assets | $41.4B | $41.9B | $44.2B | $47.8B | $48.5B | |
| Current Liabilities | $8.4B | $8.9B | $10.5B | $13.1B | $14B | |
| Total Liabilities | $30.9B | $28.6B | $29.1B | $33.6B | $33.5B | |
| Total Equity | $10.5B | $13.3B | $15.1B | $14.2B | $15B | |
| Total Debt | $12.8B | $12.8B | $14.9B | $14.7B | $14.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.7B | $3.9B | $3.5B | -$706M | -$1.6B | |
| Cash From Investing | -$1.3B | -$1.5B | -$1.7B | -$269M | -$252M | |
| Cash From Financing | -$1.1B | -$1.8B | -$3.2B | $927M | -$851M | |
| Free Cash Flow | $1.2B | $2.1B | $1.8B | -$976M | -$1.8B | |
NOC
Sector
Market Cap
$71B
$585.2M
Price % of 52-Week High
88.8%
73.78%
Dividend Yield
1.67%
0%
Shareholder Yield
3.95%
2.4%
1-Year Price Total Return
5.17%
-7.27%
Beta (5-Year)
0.151
0.781
Dividend yield:
1.67%
Annualized payout:
$8.05
Payout ratio:
32.47%
Growth streak:
21 years
Technicals
8-day SMA
Buy
Level
$482.45
200-day SMA
Sell
Level
$494.22
Bollinger Bands (100)
Buy
Level
460.82 - 504.52
Chaikin Money Flow
Buy
Level
221.6M
20-day SMA
Sell
Level
$500.33
Relative Strength Index (RSI14)
Sell
Level
49.24
ADX Line
Sell
Level
23.6
Williams %R
Neutral
Level
-54.3485
50-day SMA
Buy
Level
$491.46
MACD (12, 26)
Sell
Level
-3.60
25-day Aroon Oscillator
Sell
Level
-8
On Balance Volume
Neutral
Level
332M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.8436)
Sell
CA Score
(Annual)
Level (-0.4545)
Buy
Beneish M-Score
(Annual)
Level (-2.7092)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-0.5196)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Northrop Grumman is a diversified defense contractor providing aeronautics, defense, and space systems. The company’s aerospace segment creates the fuselage for the massive F-35 program, produces autonomous and piloted aircraft such as Global Hawk drones and the new B-21 bomber, and maintains and upgrades numerous military aircraft. Defense systems makes artillery and missile ammunition and guidance systems, long-range missiles, and missile defense systems. Mission systems creates and integrates a variety of radar, navigation, and communication systems for avionics, weapons control, and countermeasures on a range of platforms from helicopters to destroyers. Space systems produces satellites, sensors, space structures, and rocket motors.
Stock Forecast FAQ
In the current month, NOC has received 10 Buy ratings 11 Hold ratings, and 0 Sell ratings. The NOC average analyst price target in the past 3 months is $542.32.
-
Where Will Northrop Grumman Stock Be In 1 Year?
According to analysts, the consensus estimate is that Northrop Grumman share price will rise to $542.32 per share over the next 12 months.
-
What Do Analysts Say About Northrop Grumman?
Analysts are divided on their view about Northrop Grumman share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Northrop Grumman is a Sell and believe this share price will drop from its current level to $463.83.
-
What Is Northrop Grumman's Price Target?
The price target for Northrop Grumman over the next 1-year time period is forecast to be $542.32 according to 21 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 11 analysts rate the stock a Hold.
-
Is NOC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Northrop Grumman is a Hold. 11 of 21 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of NOC?
You can purchase shares of Northrop Grumman via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Northrop Grumman shares.
-
What Is The Northrop Grumman Share Price Today?
Northrop Grumman was last trading at $487.92 per share. This represents the most recent stock quote for Northrop Grumman. Yesterday, Northrop Grumman closed at $493.33 per share.
-
How To Buy Northrop Grumman Stock Online?
In order to purchase Northrop Grumman stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.07% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11% over the past day.
